Update on newer antihypertensive medicines and interventions

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


The incidence and prevalence of systemic hypertension are reaching global epidemic proportions. Despite a diverse pharmacologic armamentarium of agents to treat high blood pressure, suboptimal control remains a significant problem in as many as 43% of patients and this rate has not significantly improved over the past 2 decades. There are a variety of factors contributing to this including patient nonadherence due to complex drug regimens and medication side effects, undertreatment, and treatment resistance. There, thus, remains a need to develop novel agents and approaches to antihypertensive therapy that facilitate attainment of optimal blood pressure levels. This monograph will review a number of new pharmacologic targets and interventions as well as a novel method of drug delivery to patients.

Original languageEnglish (US)
Pages (from-to)257-267
Number of pages11
JournalJournal of Cardiovascular Pharmacology and Therapeutics
Issue number3
StatePublished - Sep 2010


  • antihypertensives
  • drug effects
  • hypertension
  • renin-angiotensin system

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)


Dive into the research topics of 'Update on newer antihypertensive medicines and interventions'. Together they form a unique fingerprint.

Cite this